PMN insider buying and SEC filings, explained
ProMIS Neurosciences Inc. · CIK 1374339
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$8.8M
Insiders who bought
5
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 30, 2026 | Purchase (code P) | Eugene Williams (Director) bought 1,316 shares at $3.99 ($5K), reported as a purchase (code P). Holdings up 11% to 13,713 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2026, 8:28 AM ET |
| Nov 2, 2026 | Purchase (code P) | Neil Cashman (Chief Scientific Officer and Director) bought 10,000 shares at $3.86 ($39K), reported as a purchase (code P). Holdings up 221% to 14,532 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2026, 8:26 AM ET |
| Aug 5, 2026 | Purchase (code P) | Johanne Kaplan (Chief Development Officer) bought 2,280 shares at $13.30 ($30K), reported as a purchase (code P). Holdings up 58% to 6,221 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Apr 22, 2026 | Purchase (code P) | Patrick D. Kirwin (Director) bought 4,000 shares indirectly (by entity) at $11.33 ($45K), reported as a purchase (code P). Holdings by entity up 613% to 4,653 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 23, 2026 |
| Mar 5, 2026 | Purchase (code P) | Eugene Williams (Director) bought 2,000 shares at $24.40 ($49K), reported as a purchase (code P). Holdings up 19% to 12,397 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 6, 2026 |
| Mar 2–4, 2026 | Purchase (code P) | Eugene Williams (Director) bought 4,000 shares between Mar 2 and Mar 4 at about $23.11 ($92K), reported as a purchase (code P). Holdings up 63% to 10,397 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Feb 19, 2026 | Purchase (code P) | Johanne Kaplan (Chief Development Officer) bought 1,629 shares at $15.35 ($25K), reported as a purchase (code P). Holdings up 70% to 3,941 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 3, 2026 | Other purchase | Slanix Paul Alex (Director) bought 700,741 shares indirectly; the filing does not report a price. New position of 700,741 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Feb 5, 2026 |
| Feb 3, 2026 | Purchase (code P) | Slanix Paul Alex (Director) bought 700,741 shares indirectly at $12.13 ($8.5M), reported as a purchase (code P). Indirect holdings up 289% to 943,090 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Feb 5, 2026 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$8.7M in purchases since Feb 3, 2026 · Purchases traded Feb 3, 2026 to Mar 5, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Slanix Paul Alex (Director) | $8.5M | Feb 3, 2026 | SEC filing |
| Johanne Kaplan (Chief Development Officer) | $25K | Feb 19, 2026 | SEC filing |
| Eugene Williams (Director) | $92K | Mar 4, 2026 | SEC filing |
| Eugene Williams (Director) | $49K | Mar 5, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PMN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.